ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ARV-471 in combination with Everolimus
Sponsor: Arvinas Estrogen Receptor, Inc.
Collaborators: Pfizer